Deutsche Bank’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,368
| Closed | -$35.4K | – | 4098 |
|
|
2022
Q4 | $35.4K | Buy |
+2,368
| New | +$32.8K | ﹤0.01% | 3660 |
|
|
2021
Q2 | – | Sell |
-46,684
| Closed | -$342K | – | 5019 |
|
|
2021
Q1 | $342K | Buy |
46,684
+31,133
| +200% | +$269K | ﹤0.01% | 3339 |
|
|
2020
Q4 | $90K | Buy |
15,551
+4,606
| +42% | +$26.4K | ﹤0.01% | 3902 |
|
|
2020
Q3 | $65K | Buy |
10,945
+4,683
| +75% | +$23.2K | ﹤0.01% | 3756 |
|
|
2020
Q2 | $32K | Buy |
+6,262
| New | +$39.5K | ﹤0.01% | 3979 |
|
|
2019
Q3 | – | Sell |
-3,231
| Closed | -$21K | – | 5493 |
|
|
2019
Q2 | $21K | Sell |
3,231
-10,392
| -76% | -$89K | ﹤0.01% | 4804 |
|
|
2019
Q1 | $110K | Sell |
13,623
-739
| -5% | -$7.63K | ﹤0.01% | 4267 |
|
|
2018
Q4 | $228K | Sell |
14,362
-9,169
| -39% | -$202K | ﹤0.01% | 3807 |
|
|
2018
Q3 | $778K | Buy |
23,531
+4,129
| +21% | +$106K | ﹤0.01% | 3507 |
|
|
2018
Q2 | $439K | Buy |
+19,402
| New | +$460K | ﹤0.01% | 3912 |
|
|
2017
Q3 | – | Sell |
-3,000
| Closed | -$66K | – | 5205 |
|
|
2017
Q2 | $66K | Buy |
+3,000
| New | +$23.6K | ﹤0.01% | 4317 |
|
|
2016
Q3 | – | Sell |
-4
| Closed | – | – | 5342 |
|
|
2016
Q2 | $0 | Buy |
+4
| New | +$39 | ﹤0.01% | 5431 |
|
|
2016
Q1 | – | Sell |
-290
| Closed | -$3K | – | 5428 |
|
|
2015
Q4 | $3K | Buy |
290
+40
| +16% | +$476 | ﹤0.01% | 5122 |
|
|
2015
Q3 | $3K | Sell |
250
-1,000
| -80% | -$14.5K | ﹤0.01% | 5090 |
|
|
2015
Q2 | $21K | Sell |
1,250
-7,527
| -86% | -$135K | ﹤0.01% | 4896 |
|
|
2015
Q1 | $126K | Buy |
8,777
+8,527
| +3,411% | +$93.2K | ﹤0.01% | 4029 |
|
|
2014
Q4 | $2K | Sell |
250
-1,981
| -89% | -$18.1K | ﹤0.01% | 6031 |
|
|
2014
Q3 | $24K | Sell |
2,231
-10,870
| -83% | -$138K | ﹤0.01% | 5150 |
|
|
2014
Q2 | $237K | Sell |
13,101
-30,185
| -70% | -$393K | ﹤0.01% | 4024 |
|
|
2014
Q1 | $646K | Sell |
43,286
-11,783
| -21% | -$212K | ﹤0.01% | 3166 |
|
|
2013
Q4 | $1.01M | Sell |
55,069
-37,316
| -40% | -$747K | ﹤0.01% | 2656 |
|
|
2013
Q3 | $1.9M | Buy |
92,385
+23,046
| +33% | +$528K | ﹤0.01% | 2521 |
|
|
2013
Q2 | $1.73M | Buy |
+69,339
| New | +$2.96M | ﹤0.01% | 2321 |
|
Deutsche Bank's AVEO Position: Q1 2023 in Review
Deutsche Bank sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 2,368 shares — an estimated $35.4K sold.
Deutsche Bank first reported a position in AVEO in Q2 2013 and held it in 23 quarters. The position peaked at $1.9M in Q3 2013. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Deutsche Bank reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Deutsche Bank sold 2,368 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $35.4K.
- Deutsche Bank first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 23 quarters.
- Deutsche Bank's AVEO Pharmaceuticals, Inc. position peaked at $1.9M in Q3 2013.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Deutsche Bank's 13F filing for Q1 2023, filed 15 May 2023.